The next era of global innovation and dealmaking in China
Converging innovation. Cross-border collaboration. Accelerating therapeutics. From cell and gene therapy breakthroughs to next-generation antibodies and bioprocessing excellence, the ChinaBio™ program tracks bring together the most promising advances shaping the future of biotechnology. Navigate five specialized summits designed to connect global leaders with China's dynamic life science ecosystem and unlock transformative partnering opportunities.
Converging innovation. Cross-border collaboration. Accelerating breakthroughs.
From cell and gene therapies to antibody engineering, bioprocessing excellence, and nucleic acid therapeutics, the ChinaBio™ Partnering Forum explores what's driving the future of life sciences across China and global markets.
Revolutionary science. Transformative treatments. Accelerating commercialization.
From CAR-T innovations to gene editing breakthroughs and scalable manufacturing solutions, the Cell & Gene Therapy Summit explores what's driving the next wave of curative medicine.
Precision targeting. Novel formats. Global pipelines.
From bispecifics and ADCs to next-generation antibody discovery platforms, the Antibody Engineering & Therapeutics Summit examines what's pushing the boundaries of biologics innovation.
Efficiency gains. Quality imperatives. Manufacturing resilience.
From continuous processing to single-use technologies and digital transformation, the Bioprocess International Conference explores what's advancing biomanufacturing excellence.
Expanding modalities. Delivery breakthroughs. Therapeutic potential.
From mRNA vaccines to siRNA therapeutics and peptide-drug conjugates, the Nucleic Acids & Peptides Summit explores what's unlocking new frontiers in precision medicine.